Curable composition, cured layer using the composition and display device including the cured layer

A curable composition with surface-modified quantum dots and a polymerizable compound addresses dispersibility and stability issues, enhancing light efficiency and processability for quantum dot applications.

KR103047643B1Active Publication Date: 2026-11-11SAMSUNG SDI CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
KR1020230078531
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-06-19
Publication Date
2026-11-11
Estimated Expiration
2043-06-19

AI Technical Summary

Technical Problem

Conventional quantum dot compositions face challenges in dispersing in polar systems due to hydrophobic surfaces, limiting light efficiency and processability, and solvent-based methods suffer from nozzle clogging and film thickness issues.

Method used

A curable composition comprising quantum dots with a specific functional group and a polymerizable compound, optimized for solvent-free formulations, enhances dispersibility and thermal stability through surface modification with a novel ligand structure, maintaining high light efficiency and processability.

Benefits of technology

The composition achieves high light retention rates and improved optical properties, suitable for ink-jetting processes, by stabilizing quantum dots with a naphthalene matrix structure, ensuring excellent dispersibility and thermal stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112023067358615-PAT00063_ABST
    Figure 112023067358615-PAT00063_ABST
Patent Text Reader

Abstract

A curable composition comprising surface-modified quantum dots and a polymerizable compound, a curable film manufactured using the curable composition, and a display device comprising the curable film are provided.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] The present invention relates to a curable composition, a cured film manufactured using the said composition, and a display device comprising the said cured film. Background Technology

[0003] In the case of conventional quantum dots, the solvents in which they can be dispersed are limited due to their hydrophobic surface characteristics, and consequently, it is true that there are significant difficulties in introducing them into polar systems such as binders or curable monomers.

[0004] For example, even in the case of quantum dot ink compositions that are being actively researched, in the initial stages, they were only dispersed to a degree that could be used in solvents for curable compositions with relatively low polarity and high hydrophobicity. Because of this, it was difficult to include more than 20 weight percent of quantum dots relative to the total amount of the composition, so the light efficiency of the ink could not be increased beyond a certain level. Even if quantum dots were forcibly added and dispersed to increase light efficiency, the viscosity exceeded the range where ink-jetting is possible, and thus processability could not be satisfied.

[0005] In addition, to achieve a viscosity range suitable for ink-jetting, a method has been used to lower the ink solid content by including more than 50% by weight of solvent relative to the total amount of the composition. Although this method also provides somewhat satisfactory results in terms of viscosity, it has the disadvantage of being difficult to apply to actual processes due to problems such as nozzle drying and clogging caused by solvent volatilization during ink-jetting, and a decrease in film thickness over time after ink-jetting, as well as severe thickness variation after curing.

[0006] Therefore, a solvent-free type of quantum dot ink is the most desirable form for actual process application, and it is assessed that the current technology of applying quantum dots themselves to solvent-based compositions has now reached its limits.

[0007] In the case of solvent-free curable compositions (quantum dot ink compositions), problems arise due to the excessive inclusion of polymerizable compounds, such as clogging and poor ejection caused by nozzle drying due to volatility, and a reduction in film thickness caused by the volatilization of the ink composition jetted within the pattern barrier pixels. Above all, the biggest problem is that it is difficult to improve the optical properties of solvent-free curable compositions. The problem to be solved

[0009] One embodiment is intended to provide a curable composition having excellent optical properties.

[0010] Another embodiment is to provide a cured film manufactured using the above-mentioned curable composition.

[0011] Another embodiment is to provide a display device including the above-mentioned hardened film. means of solving the problem

[0013] One embodiment provides a curable composition comprising (A) a quantum dot having a functional group represented by the following chemical formula 1; and (B) a polymerizable compound.

[0014] [Chemical Formula 1]

[0015]

[0016] In the above chemical formula 1,

[0017] R 1 It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0018] L 1 Silver single bond, oxygen atom, sulfur atom, NR 2 (R2 is a hydrogen atom or a C1 to C10 alkyl group) or a substituted or unsubstituted C1 to C20 alkylene group, and

[0019] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0020] L 3 It is an oxygen atom or a sulfur atom, and

[0021] m1, m2, n1, and n2 are each independently integers of 0 or 1, and

[0022] p is an integer from 0 to 100.

[0023] The above chemical formula 1 can be represented by the following chemical formula 1A.

[0024] [Chemical Formula 1A]

[0025]

[0026] In the above chemical formula 1A,

[0027] R 1 It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0028] L 1 Silver single bond, oxygen atom, sulfur atom, NR 2 (R 2 is a hydrogen atom or a C1 to C10 alkyl group) or a substituted or unsubstituted C1 to C20 alkylene group, and

[0029] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0030] L 3 It is an oxygen atom or a sulfur atom, and

[0031] m1, m2, n1, and n2 are each independently integers of 0 or 1, and

[0032] p is an integer from 0 to 100.

[0033] In the above Chemical Formula 1 and Chemical Formula 1A, R 1 is an epoxy group or a C1 to C20 alkyl group substituted with an epoxy group, m1 is an integer of 1, and m2 may be an integer of 0.

[0034] In the above Chemical Formula 1 and Chemical Formula 1A, R 1 is a thiol group or a C1 to C20 alkyl group substituted with a thiol group, m1 and m2 are each independently integers of 0, and L 1 It can be a sulfur atom.

[0035] In the above Chemical Formula 1 and Chemical Formula 1A, R 1 is a hydroxyl group or a C1 to C20 alkyl group substituted with a hydroxyl group, m1 and m2 are each independently integers of 0, and L 1 It can be an oxygen atom.

[0036] In the above Chemical Formula 1 and Chemical Formula 1A, R 1 is an amino group or a C1 to C20 alkyl group substituted with an amino group, and m1 and m2 may each be an integer of 0 independently.

[0037] In the above chemical formulas 1 and 1A, p may be an integer from 1 to 100.

[0038] The functional group represented by the above chemical formula 1 may be represented by any one of the following chemical formulas 1-1 to 1-6.

[0039] [Chemical Formula 1-1]

[0040]

[0041] [Chemical Formula 1-2]

[0042]

[0043] [Chemical Formula 1-3]

[0044]

[0045] [Chemical Formula 1-4]

[0046]

[0047] [Chemical Formula 1-5]

[0048]

[0049] [Chemical Formula 1-6]

[0050]

[0051] In the above chemical formulas 1-1 to 1-6,

[0052] p is an integer from 0 to 100.

[0053] The functional group represented by the above chemical formula 1 may be derived from a compound represented by the following chemical formula 2.

[0054] [Chemical Formula 2]

[0055]

[0056] In the above chemical formula 2,

[0057] R 1 It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0058] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0059] L 3 It is an oxygen atom or a sulfur atom, and

[0060] n1 and n2 are each independently integers of 0 or 1, and

[0061] p is an integer from 0 to 100.

[0062] The compound represented by the above chemical formula 2 may be represented by any one of the following chemical formulas 2-1 to 2-6.

[0063] [Chemical Formula 2-1]

[0064]

[0065] [Chemical Formula 2-2]

[0066]

[0067] [Chemical Formula 2-3]

[0068]

[0069] [Chemical Formula 2-4]

[0070]

[0071] [Chemical Formula 2-5]

[0072]

[0073] [Chemical Formula 2-6]

[0074]

[0075] In the above chemical formulas 2-1 to 2-6,

[0076] p is an integer from 0 to 100.

[0077] The above curable composition may be a solvent-free curable composition.

[0078] The solvent-free curable composition may comprise 5% to 60% by weight of the quantum dots and 40% to 95% by weight of the polymerizable compound, based on the total amount of the solvent-free curable composition.

[0079] The above curable composition may further include a polymerization initiator, a light diffusing agent, a polymerization inhibitor, or a combination thereof.

[0080] The light diffusing agent may include barium sulfate, calcium carbonate, titanium dioxide, zirconia, or a combination thereof.

[0081] The above curable composition may further include a solvent.

[0082] The curable composition containing the solvent may comprise, based on the total weight of the curable composition containing the solvent, 1% to 40% by weight of the quantum dots; 1% to 20% by weight of the polymerizable compound; and 40% to 80% by weight of the solvent.

[0083] The above curable composition may further include malonic acid; 3-amino-1,2-propanediol; a silane-based coupling agent; a leveling agent; a fluorine-based surfactant; or a combination thereof.

[0084] Another embodiment provides a cured film manufactured using the above-mentioned curable composition.

[0085] Another embodiment provides a display device including the above-mentioned cured film.

[0086] Specific details regarding other aspects of the present invention are included in the following detailed description. Effects of the invention

[0088] By surface-modifying the quantum dots in the quantum dot-containing curable composition with a quantum dot surface-modifying material having a composition not previously used, the optical properties of the quantum dot-containing curable composition can be improved. Brief explanation of the drawing

[0090] Figure 1 is a diagram showing the reaction of surface modifying quantum dots with a compound represented by chemical formula 2-1. Figure 2 is a diagram showing that repulsive forces between ligands are generated by the structure of the compound represented by Chemical Formula 2-1 on the surface of a quantum dot surface-modified by Chemical Formula 2-1. Specific details for implementing the invention

[0091] Hereinafter, embodiments of the present invention will be described in detail. However, these are presented as examples and are not intended to limit the present invention, and the present invention is defined only by the scope of the claims set forth below.

[0092] Unless otherwise specifically stated in this specification, "alkyl group" means a C1 to C20 alkyl group, "alkenyl group" means a C2 to C20 alkenyl group, "cycloalkenyl group" means a C3 to C20 cycloalkenyl group, "heterocycloalkenyl group" means a C3 to C20 heterocycloalkenyl group, "aryl group" means a C6 to C20 aryl group, "arylalkyl group" means a C6 to C20 arylalkyl group, "alkylene group" means a C1 to C20 alkylene group, "arylene group" means a C6 to C20 arylene group, "alkylarylene group" means a C6 to C20 alkylarylene group, "heteroarylene group" means a C3 to C20 heteroarylene group, and "alkoxylene group" means a C1 to C20 alkoxylene group It means.

[0093] Unless specifically stated in this specification, "substitution" means that at least one hydrogen atom is a halogen atom (F, Cl, Br, I), a hydroxyl group, a C1 to C20 alkoxy group, a nitro group, a cyano group, an amine group, an imino group, an azido group, an amidino group, a hydrazino group, a hydrazono group, a carbonyl group, a carbamyl group, a thiol group, an ester group, an ether group, a carboxyl group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid or a salt thereof, a C1 to C20 alkyl group, a C2 to C20 alkenyl group, a C2 to C20 alkynyl group, a C6 to C20 aryl group, a C3 to C20 cycloalkyl group, a C3 to C20 cycloalkenyl group, a C3 to C20 cycloalkynyl group, a C2 to C20 heterocycloalkyl group, a C2 to C20 heterocycloalkenyl group, a C2 to C20 It means substituted with a heterocycloalkynyl group, a C3 to C20 heteroaryl group, or a combination thereof.

[0094] Additionally, unless otherwise specifically stated in this specification, "hetero" means that the chemical formula contains at least one heteroatom among N, O, S, and P.

[0095] Additionally, unless otherwise specifically stated in this specification, "(meth)acrylate" means that both "acrylate" and "methacrylate" are possible, and "(meth)acrylic acid" means that both "acrylic acid" and "methacrylic acid" are possible.

[0096] Unless otherwise specified herein, "combination" means mixing or copolymerization.

[0097] Unless otherwise defined in the chemical formulas within this specification, if a chemical bond is not drawn at a position where a chemical bond should be drawn, it means that a hydrogen atom is bonded at said position.

[0098] Additionally, unless otherwise specifically stated in this specification, "*" signifies a part connected to the same or different atoms or chemical formulas.

[0100] The quantum dot-containing curable composition according to the present invention can achieve higher optical properties compared to existing quantum dot-containing curable compositions by surface-modifying the quantum dots using a surface-modifying material of a novel structure.

[0101] That is, the curable composition according to one embodiment relates to a photosensitive composition for a color filter applied to a display device, and more specifically, to a curable composition comprising quantum dots, which have recently become a new technological trend in the display field.

[0102] A quantum dot-containing curable composition applied to a quantum dot display includes essential components such as a photosensitive monomer (polymerizable compound), an initiator, and a light diffusing agent, similar to a conventional photoresist composition, and may additionally include a binder or a solvent. Instead of pigments / dyes to produce color characteristics, it contains quantum dots and a light diffusing agent, and the quantum dots have the function of converting incident blue light into red and green light after forming a single film.

[0103] Quantum dots, represented by CdSe and InP, have rapidly advanced in terms of luminous efficiency (Quantum Yield), and synthesis methods with luminous efficiency close to 100% are being introduced. QD SUHD TVs using quantum dot sheets have been commercialized, and currently, new QD TVs are being sold in versions that incorporate quantum dots into the CR layer of existing LED TVs to enable higher color reproduction.

[0104] The key to product development for such TVs lies in the patternability of the quantum dot-containing curable composition and how well the light efficiency of the quantum dots is maintained and patternability is realized during processes such as thermal processing, exposure, development, washing, deposition, and additional thermal processes.

[0105] However, in order to reduce the quantum dots consumed during patterning and increase productivity, including these many process steps, a new display implementation technology was needed, and an inkjetting process was introduced. For this purpose, products that implement color filters by pixel printing red quantum dot ink, green quantum dot ink, and white quantum dot ink are gaining more prominence.

[0106] As such, in all processes including quantum dot patterning and inkjetting methods, quantum dots represented by CdSe, InP, etc. undergo a thermal process, and a decrease in photo-conversion rate occurs after the thermal process. The present invention relates to a technology to solve this problem by ligating high-refractive index materials to quantum dots to create quantum dot materials that can be used in all processes such as patterning and inkjetting processes.

[0107] To date, the composition of quantum dots, particularly ink formation technology, has not been conventionally known, and there has been almost no prior research on the relationship and processability between quantum dots and ink compositions.

[0108] Quantum dots, which play a key role in blue light conversion, are surrounded by hydrophobic ligands such as oleic acid. When these hydrophobic quantum dots are converted into ink, that is, into a curable composition, a problem of poor dispersibility occurs. To solve this dispersibility problem, dispersibility is added through ligand substitution on the surface of the quantum dots, thereby enabling ink conversion.

[0109] However, since stability in thermal processes must also be considered along with such dispersibility, the present invention, as shown in FIGS. 1 and 2, modifies the surface of a quantum dot through a ligand substitution reaction with a cyclic hydrocarbon of a specific structure to suppress the decrease in light efficiency after thermal processing and to further increase the light efficiency. Due to the influence of the cyclic hydrocarbon and the substituent thereon, repulsion is formed between the ligands substituted on the surface of the quantum dot, maintaining an appropriate distance between the ligands, thereby stably surrounding the quantum dot and stabilizing it. The quantum dot surface-modified with the cyclic hydrocarbon of the specific structure can be used in any environment, such as solvent-based or solvent-free environments, and thus can have a positive effect on improving optical properties through excellent dispersibility and thermal stability.

[0110] Specifically, the present invention aims to minimize the reduction in efficiency during the thermal process included in the TV manufacturing process by liganding a high-refractive index (refractive index of 1.6 or higher) cyclic hydrocarbon onto the surface of quantum dots applied to both quantum dot-containing photoresist compositions and quantum dot-containing ink compositions, thereby achieving an increase in light efficiency compared to existing methods and ultimately increasing the light retention rate to 99% or higher.

[0111] A curable composition according to one embodiment comprises (A) quantum dots comprising a functional group represented by the following chemical formula 1; and (B) a polymerizable compound.

[0112] [Chemical Formula 1]

[0113]

[0114] In the above chemical formula 1,

[0115] R 1 It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0116] L 1 Silver single bond, oxygen atom, sulfur atom, NR 2 (R 2 is a hydrogen atom or a C1 to C10 alkyl group) or a substituted or unsubstituted C1 to C20 alkylene group, and

[0117] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0118] L 3 It is an oxygen atom or a sulfur atom, and

[0119] m1, m2, n1, and n2 are each independently integers of 0 or 1, and

[0120] p is an integer from 0 to 100.

[0121] The curable composition according to one embodiment includes quantum dots comprising a functional group represented by the above chemical formula 1, so it has excellent high-temperature storage stability, particularly viscosity characteristics, and can maintain a high light retention rate even when a thermal process is carried out at a temperature of 180°C or higher.

[0122] Each component constituting the curable composition according to one embodiment will be described in detail below.

[0124] quantum dots

[0125] Various ligand structures capable of passivating the surface of quantum dots with organic ligands are known; among these, carboxylic acid ligands have relatively weak interactions with the quantum dot surface, while phosphoric acid ligands offer good dispersibility but have a weakness that reduces efficiency (causing color change).

[0126] Accordingly, the present invention relates to a quantum dot-containing curable composition with excellent light resistance, which can maintain its initial light efficiency even when exposed for a long time to strong blue light, such as that of a micro LED, when the quantum dot-containing curable composition surface-modified with the surface-modifying material is mounted on a display panel in a single-film state, by using a naphthalene ring structure as a matrix for effective passivation of the quantum dot surface and controlling the substituent structure to have a specific structure of substituents, and further controlling the number and position of said substituents simultaneously.

[0127] For example, the above chemical formula 1 can be represented by the following chemical formula 1A.

[0128] [Chemical Formula 1A]

[0129]

[0130] In the above chemical formula 1A,

[0131] R 1 It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0132] L 1 Silver single bond, oxygen atom, sulfur atom, NR 2 (R 2 is a hydrogen atom or a C1 to C10 alkyl group) or a substituted or unsubstituted C1 to C20 alkylene group, and

[0133] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0134] L 3 It is an oxygen atom or a sulfur atom, and

[0135] m1, m2, n1, and n2 are each independently integers of 0 or 1, and

[0136] p is an integer from 0 to 100.

[0137] For example, in the above Chemical Formula 1 and Chemical Formula 1A, R 1 is an epoxy group or a C1 to C20 alkyl group substituted with an epoxy group, m1 is an integer of 1, and m2 may be an integer of 0.

[0138] For example, in the above Chemical Formula 1 and Chemical Formula 1A, R 1 is a thiol group or a C1 to C20 alkyl group substituted with a thiol group, m1 and m2 are each independently integers of 0, and L 1 It can be a sulfur atom.

[0139] For example, in the above Chemical Formula 1 and Chemical Formula 1A, R 1 is a hydroxyl group or a C1 to C20 alkyl group substituted with a hydroxyl group, m1 and m2 are each independently integers of 0, and L 1 It can be an oxygen atom.

[0140] For example, in the above Chemical Formula 1 and Chemical Formula 1A, R 1 is an amino group or a C1 to C20 alkyl group substituted with an amino group, and m1 and m2 can each independently be an integer of 0.

[0141] For example, in the above Chemical Formula 1 and Chemical Formula 1A, R 1 In the case where this is an epoxy group, a thiol group, or a C1 to C20 alkyl group substituted with an epoxy group or a thiol group, the optical properties of a curable composition containing quantum dots having such functional groups may be the best.

[0142] The functional group represented by the above chemical formula 1 or chemical formula 1A has a naphthalene structure as its matrix, and since naphthalene has excellent optical properties, it can be advantageous for securing excellent optical properties.

[0143] In addition, due to the repulsive force between the parent naphthalene structures and the repulsive force between the substituents achievable in the naphthalene structures, the functional groups represented by Chemical Formula 1 or Chemical Formula 1A can be stably positioned around the quantum dots, resulting in excellent quantum dot passivation effects, which leads to an improvement in optical properties.

[0144] However, if naphthalene is not used as the matrix structure, or even if naphthalene is used as the matrix structure, the number of substituents substituted on naphthalene is 1, or even if the number of substituents substituted on naphthalene is 2, the two substituents are substituted on each of the two benzene rings constituting naphthalene, it may be difficult to improve optical properties.

[0145] As mentioned above, naphthalene was selected as the matrix because of its excellent optical properties; therefore, if a compound with a structure other than naphthalene is used as the matrix, it is inevitably disadvantageous to secure optical properties. Even if naphthalene is used as the matrix, if there is only one substituent, the single substituent is used for surface modification on the surface of the quantum dot, so repulsion between surface modification materials is not well formed, making it impossible to stably passivate the quantum dot. Even if two substituents are substituted on the naphthalene ring, if the substitution positions are each substituted on one of the two benzene rings constituting the naphthalene, the quantum dot passivation effect is significantly reduced, similar to the case where there is only one substituent, making it difficult to improve optical properties.

[0146] For example, in the above Chemical Formula 1 and Chemical Formula 1A, p may be an integer from 1 to 100. When p is an integer greater than or equal to 1, there are two or more naphthalene ring structures within the functional group, thereby ensuring superior optical properties.

[0147] For example, the functional group represented by the above chemical formula 1 may be represented by any one of the following chemical formulas 1-1 to 1-6, but is not necessarily limited thereto.

[0148] [Chemical Formula 1-1]

[0149]

[0150] [Chemical Formula 1-2]

[0151]

[0152] [Chemical Formula 1-3]

[0153]

[0154] [Chemical Formula 1-4]

[0155]

[0156] [Chemical Formula 1-5]

[0157]

[0158] [Chemical Formula 1-6]

[0159]

[0160] In the above chemical formulas 1-1 to 1-6,

[0161] p is an integer from 0 to 100.

[0162] Meanwhile, the functional group represented by the above chemical formula 1 may be derived from a compound represented by the following chemical formula 2.

[0163] [Chemical Formula 2]

[0164]

[0165] In the above chemical formula 2,

[0166] R 1It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0167] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0168] L 3 It is an oxygen atom or a sulfur atom, and

[0169] n1 and n2 are each independently integers of 0 or 1, and

[0170] p is an integer from 0 to 100.

[0171] For example, the above chemical formula 2 can be represented by the following chemical formula 2A.

[0172] [Chemical Formula 2A]

[0173]

[0174] In the above chemical formula 2A,

[0175] R 1 It is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and

[0176] L 2 is a substituted or unsubstituted C1 to C20 alkylene group, and

[0177] L 3 It is an oxygen atom or a sulfur atom, and

[0178] n1 and n2 are each independently integers of 0 or 1, and

[0179] p is an integer from 0 to 100.

[0180] For example, in the above Chemical Formula 2 and Chemical Formula 2A, R 1 It may be an epoxy group or a C1 to C20 alkyl group substituted with an epoxy group.

[0181] For example, in the above Chemical Formula 2 and Chemical Formula 2A, R 1 It may be a thiol group or a C1 to C20 alkyl group substituted with a thiol group.

[0182] For example, in the above Chemical Formula 2 and Chemical Formula 2A, R 1 It may be a hydroxyl group or a C1 to C20 alkyl group substituted with a hydroxyl group.

[0183] For example, in the above Chemical Formula 2 and Chemical Formula 2A, R 1 It may be an amino group or a C1 to C20 alkyl group substituted with an amino group.

[0184] For example, in the above Chemical Formula 2 and Chemical Formula 2A, R 1 In the case where this is an epoxy group, a thiol group, or a C1 to C20 alkyl group substituted with an epoxy group or a thiol group, the optical properties of a curable composition containing quantum dots surface-modified with such a surface-modifying material may be the best.

[0185] For example, the compound (surface modifying material) represented by the above chemical formula 2 may be represented by any one of the following chemical formulas 2-1 to 2-6, but is not necessarily limited thereto.

[0186] [Chemical Formula 2-1]

[0187]

[0188] [Chemical Formula 2-2]

[0189]

[0190] [Chemical Formula 2-3]

[0191]

[0192] [Chemical Formula 2-4]

[0193]

[0194] [Chemical Formula 2-5]

[0195]

[0196] [Chemical Formula 2-6]

[0197]

[0198] In the above chemical formulas 2-1 to 2-6,

[0199] p is an integer from 0 to 100.

[0200] When quantum dots containing a functional group represented by Chemical Formula 1, that is, quantum dots surface-modified with a compound represented by Chemical Formula 2, are added to a polymerizable compound described later and stirred, a very transparent dispersion can be obtained, which serves as a measure confirming that the surface modification of the quantum dots is very well done.

[0201] For example, when the curable composition according to one embodiment is a solvent-free curable composition, the quantum dots may be included in an amount of 5% to 60% by weight, for example, 10% to 60% by weight, for example, 20% to 60% by weight, for example, 30% to 50% by weight. When the quantum dots are included within the above range, high light retention rate and light efficiency can be achieved even after curing.

[0202] For example, when the curable composition according to one embodiment is a curable composition containing a solvent, the quantum dots may be included in an amount of 1% to 40% by weight, for example, 3% to 30% by weight, relative to the total amount of the curable composition. When the quantum dots are included within the above range, the photoconversion rate is excellent, and excellent processability can be achieved without impairing pattern characteristics and development characteristics.

[0203] For example, the above quantum dot absorbs light in a wavelength range of 360 nm to 780 nm, e.g., a wavelength range of 400 nm to 780 nm, and can emit fluorescence in a wavelength range of 500 nm to 700 nm, e.g., 500 nm to 580 nm, or emit fluorescence at 600 nm to 680 nm. That is, the above quantum dot has a maximum fluorescence emission wavelength (fluorescence λ) at 500 nm to 680 nm. em Can have ).

[0204] Each of the above quantum dots can independently have a full width at half maximum (FWHM) of 20 nm to 100 nm, for example, 20 nm to 50 nm. When the quantum dots have a full width at half maximum within the above range, the color purity is high, so when used as a color material in a color filter, there is an effect of increasing the color reproduction rate.

[0205] Each of the above quantum dots may independently be organic, inorganic, or a hybrid of organic and inorganic materials.

[0206] The above quantum dots may each independently be composed of a core and a shell surrounding the core, and the core and shell may each independently have structures such as a core, core / shell, core / first shell / second shell, alloy, alloy / shell, etc., composed of Group II-IV, Group III-V, etc., but are not limited thereto.

[0207] For example, the core may comprise at least one material selected from the group consisting of CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, GaN, GaP, GaAs, InP, InAs, and alloys thereof, but is not necessarily limited thereto. The shell surrounding the core may comprise at least one material selected from the group consisting of CdSe, ZnSe, ZnS, ZnTe, CdTe, PbS, TiO, SrSe, HgSe, and alloys thereof, but is not necessarily limited thereto.

[0208] In one embodiment, as global interest in the environment has recently increased significantly and regulations on toxic substances are being strengthened, an environmentally friendly non-cadmium light-emitting material (InP / ZnS, InP / ZeSe / ZnS, etc.) with a somewhat lower quantum yield was used instead of a light-emitting material having a cadmium-based core, but it is not necessarily limited to this.

[0209] In the case of the above-mentioned core / shell structured quantum dots, the size (average particle size) of each of the total quantum dots including the shell may be 1 nm to 15 nm, for example, 5 nm to 15 nm.

[0210] For example, the above quantum dots may each independently include red quantum dots, green quantum dots, or a combination thereof. Each of the above red quantum dots may each independently have an average particle size of 10 nm to 15 nm. Each of the above green quantum dots may each independently have an average particle size of 5 nm to 8 nm.

[0211] Meanwhile, to ensure dispersion stability of the quantum dots, the curable composition according to one embodiment may further include a dispersant. The dispersant helps to uniformly disperse a photoconversion material, such as quantum dots, within the curable composition, and may be a nonionic, anionic, or cationic dispersant. Specifically, polyalkylene glycol or esters thereof, polyoxyalkylene, polyhydric alcohol ester alkylene oxide adduct, alcohol alkylene oxide adduct, sulfonic acid ester, sulfonic acid salt, carboxylic acid ester, carboxylic acid salt, alkylamide alkylene oxide adduct, alkyl amine, etc., may be used, and these may be used alone or in a mixture of two or more. The dispersant may be used in an amount of 0.1% to 100% by weight, for example, 10% to 20% by weight, relative to the solid content of the photoconversion material, such as quantum dots.

[0213] polymerizable compounds

[0214] A curable composition according to one embodiment comprises a polymerizable compound, and the polymerizable compound may have a carbon-carbon double bond at its terminal.

[0215] The polymerizable compound having a carbon-carbon double bond at the terminal end may be included in an amount of 40% to 95% by weight, for example, 50% to 90% by weight, relative to the total amount of the solvent-free curable composition. The content of the polymerizable compound having a carbon-carbon double bond at the terminal end must be within the above range to enable the production of a solvent-free curable composition having a viscosity suitable for ink jetting, and furthermore, the quantum dots in the produced solvent-free curable composition may have excellent dispersibility, thereby improving optical properties.

[0216] For example, the polymerizable compound having a carbon-carbon double bond at the end may have a molecular weight of 170 g / mol to 1,000 g / mol. When the molecular weight of the polymerizable compound having a carbon-carbon double bond at the end is within the above range, it may be advantageous for ink-jetting as it does not impair the optical properties of the quantum dots and does not increase the viscosity of the composition.

[0217] For example, a polymerizable compound having a carbon-carbon double bond at the above-mentioned end can be represented by the following chemical formula 6, but is not necessarily limited thereto.

[0218] [Chemical Formula 6]

[0219]

[0220] In the above chemical formula 6,

[0221] R 6 and R 7 Each is independently a hydrogen atom or a substituted or unsubstituted C1 to C10 alkyl group, and

[0222] L 8 and L 10 Each is independently a single-bonded, substituted, or unsubstituted C1 to C10 alkylene group, and

[0223] L 9 is a substituted or unsubstituted C1 to C10 alkylene group, a substituted or unsubstituted C3 to C20 cycloalkylene group or an ether group (*-O-*).

[0224] For example, polymerizable compounds having a carbon-carbon double bond at the above-mentioned end may be represented by the following chemical formula 6-1, chemical formula 6-2, or chemical formula 6-3, but are not necessarily limited thereto.

[0225] [Chemical Formula 6-1]

[0226]

[0227] [Chemical Formula 6-2]

[0228]

[0229] [Chemical Formula 6-3]

[0230]

[0231] For example, polymerizable compounds having a carbon-carbon double bond at the terminal end include, in addition to the compounds represented by Formula 6-1, Formula 6-2, or Formula 6-3, ethylene glycol diacrylate, triethylene glycol diacrylate, 1,4-butanediol diacrylate, 1,6-hexanediol diacrylate, neopentyl glycol diacrylate, pentaerythritol diacrylate, pentaerythritol triacrylate, dipentaerythritol diacrylate, dipentaerythritol triacrylate, dipentaerythritol pentaacrylate, pentaerythritol hexaacrylate, bisphenol A diacrylate, trimethylolpropane triacrylate, novolac epoxyacrylate, ethylene glycol dimethacrylate, triethylene glycol dimethacrylate, propylene glycol dimethacrylate, It may further include 1,4-butanediol dimethacrylate, 1,6-hexanediol dimethacrylate, or a combination thereof.

[0232] In addition, the polymerizable compound having a carbon-carbon double bond at the terminal end may further include a monomer commonly used in conventional thermosetting or photocurable compositions, for example, the monomer may further include an oxetane-based compound such as bis[1-ethyl(3-oxetanyl)]methyl ether.

[0233] In addition, if the curable composition includes a solvent, the polymerizable compound may be included in an amount of 1% to 20% by weight, 1% to 15% by weight, for example, 5% to 15% by weight, relative to the total amount of the curable composition. When the polymerizable compound is included within the above range, the optical properties of the quantum dots can be improved.

[0235] light diffuser

[0236] A curable composition according to one embodiment may further include a light diffusing agent.

[0237] For example, the light diffusing agent may include barium sulfate (BaSO4), calcium carbonate (CaCO3), titanium dioxide (TiO2), zirconia (ZrO2), or a combination thereof.

[0238] The light diffusing agent above reflects light that is not absorbed by the aforementioned quantum dots and enables the quantum dots to reabsorb the reflected light. That is, the light diffusing agent increases the amount of light absorbed by the quantum dots, thereby increasing the light conversion efficiency of the curable composition.

[0239] The above light diffusing agent has an average particle size (D 50 The average particle size of the light diffusing agent may be 150 nm to 250 nm, and specifically, 180 nm to 230 nm. When the average particle size of the light diffusing agent is within the above range, it may have a superior light diffusing effect and increase light conversion efficiency.

[0240] The light diffusing agent may be included in an amount of 1% to 20% by weight, for example, 2% to 15% by weight, for example, 3% to 10% by weight, relative to the total amount of the curable composition. If the light diffusing agent is included in an amount of less than 1% by weight relative to the total amount of the curable composition, it is difficult to expect an improvement in light conversion efficiency due to the use of the light diffusing agent, and if it is included in an amount exceeding 20% ​​by weight, there is a risk that a problem of quantum dot sedimentation may occur.

[0242] Polymerization initiator

[0243] A curable composition according to one embodiment may further include a polymerization initiator, for example, a photopolymerization initiator, a thermal polymerization initiator, or a combination thereof.

[0244] The above photopolymerization initiator is an initiator generally used in photosensitive resin compositions, and examples include acetophenone-based compounds, benzophenone-based compounds, thioxanthone-based compounds, benzoin-based compounds, triazine-based compounds, oxime-based compounds, aminoketone-based compounds, etc., but are not necessarily limited thereto.

[0245] Examples of the above acetophenone-based compounds include 2,2'-diethoxyacetophenone, 2,2'-dibutoxyacetophenone, 2-hydroxy-2-methylpropiophenone, pt-butyltrichloroacetophenone, pt-butyldichloroacetophenone, 4-chloroacetophenone, 2,2'-dichloro-4-phenoxyacetophenone, 2-methyl-1-(4-(methylthio)phenyl)-2-morpholinopropan-1-one, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one, etc.

[0246] Examples of the above benzophenone compounds include benzophenone, benzoyl benzoic acid, methyl benzoyl benzoate, 4-phenyl benzophenone, hydroxybenzophenone, acrylated benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, 4,4'-dimethylaminobenzophenone, 4,4'-dichlorobenzophenone, 3,3'-dimethyl-2-methoxybenzophenone, etc.

[0247] Examples of the above thioxanthonic compounds include thioxanthon, 2-methylthioxanthon, isopropylthioxanthon, 2,4-diethylthioxanthon, 2,4-diisopropylthioxanthon, 2-chlorothioxanthon, etc.

[0248] Examples of the above-mentioned benzoin compounds include benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, benzyl dimethyl ketal, etc.

[0249] Examples of the above triazine compounds include 2,4,6-trichloro-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(3',4'-dimethoxystyryl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4'-methoxynaphthyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-tolyl)-4,6-bis(trichloromethyl)-s-triazine, 2-biphenyl-4,6-bis(trichloromethyl)-s-triazine, and bis(trichloromethyl)-6-styryl-s-triazine. Examples include 2-(naphtho-1-yl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-methoxynaphtho-1-yl)-4,6-bis(trichloromethyl)-s-triazine, 2-4-bis(trichloromethyl)-6-piperonyl-s-triazine, 2-4-bis(trichloromethyl)-6-(4-methoxystyryl)-s-triazine, etc.

[0250] Examples of the above oxime compounds include O-acyloxime compounds, 2-(O-benzoyloxime)-1-[4-(phenylthio)phenyl]-1,2-octanedione, 1-(O-acetyloxime)-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]ethanolone, O-ethoxycarbonyl-α-oxyamino-1-phenylpropan-1-one, etc. Specific examples of the above O-acyloxime compounds include 1,2-octanedione, 2-dimethylamino-2-(4-methylbenzyl)-1-(4-morpholine-4-yl-phenyl)-butan-1-one, 1-(4-phenylsulfanylphenyl)-butan-1,2-dione-2-oxime-O-benzoate, 1-(4-phenylsulfanylphenyl)-octan-1,2-dione-2-oxime-O-benzoate, 1-(4-phenylsulfanylphenyl)-octan-1-one-oxime-O-acetate, and 1-(4-phenylsulfanylphenyl)-butan-1-one-oxime-O-acetate.

[0251] Examples of the above aminoketone compounds include 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1 (2-Benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1).

[0252] In addition to the above compounds, the above photopolymerization initiator may use carbazole compounds, diketone compounds, sulfonium borate compounds, diazo compounds, imidazole compounds, non-imidazole compounds, etc.

[0253] The above photopolymerization initiator may also be used in combination with a photosensitizer that causes a chemical reaction by absorbing light, becoming excited, and then transferring that energy.

[0254] Examples of the above-mentioned photosensitizers include tetraethylene glycol bis-3-mercaptopropionate, pentaerythritol tetrakis-3-mercaptopropionate, dipentaerythritol tetrakis-3-mercaptopropionate, etc.

[0255] Examples of the above-mentioned thermal polymerization initiators include peroxides, specifically benzoyl peroxide, dibenzoyl peroxide, lauryl peroxide, di-lauryl peroxide, di-tert-butyl peroxide, cyclohexane peroxide, methyl ethyl ketone peroxide, hydroperoxides (e.g., tert-butyl hydroperoxide, cumene hydroperoxide), dicyclohexyl peroxydicarbonate, 2,2-azobis(isobutyronitrile), t-butyl perbenzoate, etc., and 2,2'-azobis-2-methylpropionitrile, etc., but are not necessarily limited thereto, and any that is widely known in the art may be used.

[0256] The polymerization initiator may be included in an amount of 0.1% to 5% by weight, for example, 1% to 4% by weight, relative to the total amount of the curable composition. When the polymerization initiator is included within the above range, sufficient curing occurs during photolithography or thermal curing, thereby obtaining excellent reliability, and the decrease in transmittance caused by unreacted initiator can be prevented, thereby preventing the deterioration of the optical properties of the quantum dots.

[0258] Binder resin

[0259] A curable composition according to one embodiment may further include a binder resin.

[0260] The above binder resin may include acrylic resin, cardo resin, epoxy resin, or a combination thereof.

[0261] The above acrylic resin may be a copolymer of a first ethylenically unsaturated monomer and a second ethylenically unsaturated monomer copolymerizable thereto, and may be a resin comprising one or more acrylic repeating units.

[0262] Specific examples of the above-mentioned acrylic binder resins include polybenzyl methacrylate, (meth)acrylic acid / benzyl methacrylate copolymer, (meth)acrylic acid / benzyl methacrylate / styrene copolymer, (meth)acrylic acid / benzyl methacrylate / 2-hydroxyethyl methacrylate copolymer, (meth)acrylic acid / benzyl methacrylate / styrene / 2-hydroxyethyl methacrylate copolymer, but are not limited thereto, and these may be used alone or in combination of two or more types.

[0263] The weight-average molecular weight of the above acrylic resin may be 5,000 g / mol to 15,000 g / mol.   When the weight-average molecular weight of the above acrylic resin is within the above range, the adhesion to the substrate is excellent, the physical and chemical properties are good, and the viscosity is appropriate.

[0264] The acid value of the above acrylic resin may be 80 mgKOH / g to 130 mgKOH / g. When the acid value of the above acrylic resin is within the above range, the resolution of the pixel pattern is excellent.

[0265] The above cardo-based resin may be one used in conventional curable resin (or photosensitive resin) compositions, for example, one disclosed in Korean Patent Publication No. 10-2018-0067243, but is not limited thereto.

[0266] The above cardo-based resin comprises, for example, fluorene-containing compounds such as 9,9-bis(4-oxyranylmethoxyphenyl)fluorene; anhydride compounds such as benzenetetracarboxylic acid dihydride, naphthalenetetracarboxylic acid dihydride, biphenyltetracarboxylic acid dihydride, benzophenonetetracarboxylic acid dihydride, pyromellitic dihydride, cyclobutanetetracarboxylic acid dihydride, perylenetetracarboxylic acid dihydride, tetrahydrofurantetracarboxylic acid dihydride, tetrahydrophthalic anhydride; glycol compounds such as ethylene glycol, propylene glycol, and polyethylene glycol; alcohol compounds such as methanol, ethanol, propanol, n-butanol, cyclohexanol, and benzyl alcohol; solvent compounds such as propylene glycol methyl ethyl acetate and N-methylpyrrolidone; and phosphorus compounds such as triphenylphosphine. It can be prepared by mixing two or more of amine or ammonium salt compounds such as tetramethylammonium chloride, tetraethylammonium bromide, benzyl diethylamine, triethylamine, tributylamine, and benzyl triethylammonium chloride.

[0267] The weight-average molecular weight of the above cardo-based resin may be 500 g / mol to 50,000 g / mol, for example, 1,000 g / mol to 30,000 g / mol. When the weight-average molecular weight of the above cardo-based resin is within the above range, pattern formation is good without residue when manufacturing a cured film, there is no loss of film thickness when developing the curable composition, and a good pattern can be obtained.

[0268] When the above binder resin is a cardo-based resin, the curable composition containing it, particularly the photosensitive resin composition, has excellent developability and good sensitivity during photocuring, resulting in excellent fine pattern formation ability.

[0269] The above epoxy resin may include monomers or oligomers that can be polymerized by heat, and may include compounds having carbon-carbon unsaturated bonds and carbon-carbon cyclic bonds.

[0270] The above epoxy resins may include bisphenol A type epoxy resin, bisphenol F type epoxy resin, phenol novolak type epoxy resin, cyclic aliphatic epoxy resin, and aliphatic polyglycidyl ether, but are not necessarily limited thereto.

[0271] Commercial products of these compounds include, for bisphenyl epoxy resins, YX4000, YX4000H, YL6121H, YL6640, and YL6677 of Yukka Shell Epoxy Co., Ltd.; for cresol novolak type epoxy resins, EOCN-102, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025, and EOCN-1027 of Nippon Kayaku Co., Ltd. and Epicoat 180S75 of Yukka Shell Epoxy Co., Ltd.; for bisphenol A type epoxy resins, Epicoat 1001, 1002, 1003, 1004, 1007, 1009, 1010, and 828 of Yukka Shell Epoxy Co., Ltd.; Bisphenol F type epoxy resins include Epicoat 807 and 834 of Yukka Shell Epoxy Co., Ltd.; phenol novolac type epoxy resins include Epicoat 152, 154, and 157H65 of Yukka Shell Epoxy Co., Ltd. and EPPN 201 and 202 of Nippon Kayaku Co., Ltd.; Other cyclic aliphatic epoxy resins include CIBA-GEIGY AG's CY175, CY177, and CY179; UCC's ERL-4234, ERL-4299, ERL-4221, and ERL-4206; Showa Denko Co., Ltd.'s Shodine 509; CIBA-GEIGY AG's Araldite CY-182, CY-192, and CY-184; Dainippon Ink Kogyo Co., Ltd.'s Epichron 200 and 400; Yukka Shell Epoxy Co., Ltd.'s Epicoat 871, 872, and EP1032H60; and Celanese Coating Co., Ltd.'s ED-5661 and ED-5662; Examples of aliphatic polyglycidyl ethers include Epicoat 190P and 191P from Yuka Shell Epoxy Co., Ltd., Epolite 100MF from Kyoesha Yushi Kagaku Kogyo Co., Ltd., and Epiol TMP from Nippon Yushi Co., Ltd.

[0272] For example, when the curable composition according to one embodiment is a solvent-free curable composition, the binder resin may be included in an amount of 0.5% to 10% by weight, for example, 1% to 5% by weight, based on the total amount of the curable composition. In this case, the heat resistance and chemical resistance of the solvent-free curable composition can be improved, and the storage stability of the composition can also be improved.

[0273] For example, if the curable composition according to one embodiment is a curable composition containing a solvent, the binder resin may be included in an amount of 1% to 30% by weight, for example, 3% to 20% by weight, based on the total amount of the curable composition. In this case, excellent pattern characteristics, heat resistance, and chemical resistance can be improved.

[0275] Other additives

[0276] To improve the stability and dispersibility of the above quantum dots, the curable composition according to one embodiment may further include a polymerization inhibitor.

[0277] The polymerization inhibitor may include hydroquinone-based compounds, catechol-based compounds, or combinations thereof, but is not necessarily limited thereto. As the curable composition according to one embodiment further includes the hydroquinone-based compounds, catechol-based compounds, or combinations thereof, room temperature crosslinking can be prevented during exposure after printing (coating) the curable composition.

[0278] For example, the above hydroquinone-based compound, catechol-based compound, or combination thereof is hydroquinone, methyl hydroquinone, methoxyhydroquinone, t-butyl hydroquinone, 2,5-di- t -Butyl hydroquinone, 2,5-bis(1,1-dimethylbutyl) hydroquinone, 2,5-bis(1,1,3,3-tetramethylbutyl) hydroquinone, catechol, t-butyl catechol, 4-methoxyphenol, pyrogallol, 2,6-di- t- It may include butyl-4-methylphenol, 2-naphthol, tris(N-hydroxy-N-nitrosophenylaminato-O,O')aluminium, or a combination thereof, but is not necessarily limited thereto.

[0279] The above hydroquinone-based compound, catechol-based compound, or a combination thereof may be used in the form of a dispersion, and the polymerization inhibitor in the form of the dispersion may be included in an amount of 0.001% to 3% by weight, for example, 0.01% to 2% by weight, based on the total amount of the curable composition. When the polymerization inhibitor is included within the above range, the problem of deterioration over time at room temperature can be solved, while simultaneously preventing a decrease in sensitivity and surface peeling.

[0280] In addition, the curable composition according to one embodiment may further include malonic acid; 3-amino-1,2-propanediol; a silane-based coupling agent; a leveling agent; a fluorine-based surfactant; or a combination thereof to improve heat resistance and reliability.

[0281] For example, a curable composition according to one embodiment may further include a silane-based coupling agent having reactive substituents such as vinyl groups, carboxyl groups, methacrylate groups, isocyanate groups, and epoxy groups to improve adhesion to a substrate.

[0282] Examples of the above-mentioned silane coupling agents include trimethoxysilyl benzoic acid, γ-methacrylate oxypropyl trimethoxysilane, vinyl triacetoxysilane, vinyl trimethoxysilane, γ-isocyanate propyl triethoxysilane, γ-glycidoxypropyl trimethoxysilane, β-epoxycyclohexyl ethyl trimethoxysilane, etc., and these may be used alone or in a mixture of two or more types.

[0283] The above silane-based coupling agent may be included in an amount of 0.01 to 10 parts by weight per 100 parts by weight of the above curable composition. When the silane-based coupling agent is included within the above range, adhesion, storage stability, etc. are excellent.

[0284] In addition, the above-mentioned curable composition may further include a surfactant, such as a fluorine-based surfactant, as needed to improve coating properties and prevent defect formation, that is, to improve leveling performance.

[0285] The above-mentioned fluorine-based surfactant may have a low weight-average molecular weight of 4,000 g / mol to 10,000 g / mol, specifically 6,000 g / mol to 10,000 g / mol. Additionally, the above-mentioned fluorine-based surfactant may have a surface tension of 18 mN / m to 23 mN / m (measured in a 0.1% propylene glycol monomethyl ether acetate (PGMEA) solution). When the weight-average molecular weight and surface tension of the above-mentioned fluorine-based surfactant are within the above ranges, leveling performance can be further improved, staining can be prevented during high-speed coating, and since there is less bubble generation and fewer film defects, it provides excellent characteristics for slit coating, a high-speed coating method.

[0286] The above-mentioned fluorine-based surfactant is BM-1000 of BM Chemie. ® , BM-1100 ® Etc.; Mecha Pack F 142D of Dai Nippon Inki Gagaku High School Co., Ltd. ® , East F 172 ® , East F 173 ® , East F 183 ® Etc.; Sumitomo 3M Corporation’s Prorad FC-135 ® , same FC-170C ® , East FC-430 ® , East FC-431 ®Etc.; Asahi Glass Co., Ltd.'s Saffron S-112 ® , East S-113 ® , East S-131 ® , East S-141 ® , same S-145 ® Etc.; SH-28PA of Toray Silicon Co., Ltd. ® , Dong-190 ® , Dong-193 ® , SZ-6032 ® , SF-8428 ® Fluorine-based surfactants marketed under names such as F-482, F-484, F-478, F-554, etc. by DIC Co., Ltd. may be used.

[0287] In addition, the curable composition according to one embodiment may use a silicone-based surfactant together with the aforementioned fluorine-based surfactant. Specific examples of the silicone-based surfactant include, but are not limited to, TSF400, TSF401, TSF410, and TSF4440 of Toshiba Silicon.

[0288] The surfactant, including the above-mentioned fluorine-based surfactant, etc., may be included in an amount of 0.01 to 5 parts by weight, for example, 0.1 to 2 parts by weight, per 100 parts by weight of the above-mentioned curable composition. When the above-mentioned surfactant is included within the above range, the phenomenon of foreign matter occurring in the sprayed composition is reduced.

[0289] In addition, the curable composition according to one embodiment may further include a certain amount of other additives, such as antioxidants, within a range that does not impair physical properties.

[0291] menstruum

[0292] Meanwhile, the curable composition according to one embodiment may further include a solvent.

[0293] The above solvent is, for example, alcohols such as methanol and ethanol; glycol ethers such as ethylene glycol methyl ether, ethylene glycol ethyl ether, and propylene glycol methyl ether; cellosolve acetates such as methyl cellosolve acetate, ethyl cellosolve acetate, and diethyl cellosolve acetate; carbitols such as methyl ethyl carbitol, diethyl carbitol, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol dimethyl ether, diethylene glycol methyl ethyl ether, and diethylene glycol diethyl ether; and propylene glycol alkyl ether acetates such as propylene glycol monomethyl ether acetate and propylene glycol propyl ether acetate. Ketones such as methyl ethyl ketone, cyclohexanone, 4-hydroxy-4-methyl-2-pentanone, methyl-n-propyl ketone, methyl-n-butyl ketone, methyl-n-amyl ketone, 2-heptanone; saturated aliphatic monocarboxylic acid alkyl esters such as ethyl acetate, n-butyl acetate, isobutyl acetate; lactic acid alkyl esters such as methyl lactate, ethyl lactate; hydroxyacetate alkyl esters such as methyl hydroxyacetate, ethyl hydroxyacetate, butyl hydroxyacetate; acetate alkoxyalkyl esters such as methoxymethyl acetate, methoxyethyl acetate, methoxybutyl acetate, ethoxymethyl acetate, ethoxyethyl acetate; Alkyl esters of 3-hydroxypropionates such as methyl 3-hydroxypropionate and ethyl 3-hydroxypropionate; alkyl esters of 3-alkoxypropionates such as methyl 3-methoxypropionate, ethyl 3-methoxypropionate, ethyl 3-ethoxypropionate, and methyl 3-ethoxypropionate; alkyl esters of 2-hydroxypropionates such as methyl 2-hydroxypropionate, ethyl 2-hydroxypropionate, and propyl 2-hydroxypropionate; alkyl esters of 2-alkoxypropionates such as methyl 2-methoxypropionate, ethyl 2-methoxypropionate, ethyl 2-ethoxypropionate, and methyl 2-ethoxypropionate;Alkyl esters of 2-hydroxy-2-methylpropionate such as methyl 2-hydroxy-2-methylpropionate and ethyl 2-hydroxy-2-methylpropionate; alkyl esters of 2-alkoxy-2-methylpropionate such as methyl 2-methoxy-2-methylpropionate and ethyl 2-ethoxy-2-methylpropionate; esters such as 2-hydroxyethylpropionate, 2-hydroxy-2-methylethylpropionate, hydroxyethyl acetate, and methyl 2-hydroxy-3-methylbutanoate; Alternatively, there are compounds of ketone acid esters such as ethyl pyruvate, and examples include, but are not limited to, N-methylformamide, N,N-dimethylformamide, N-methylformanilide, N-methylacetamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethyl sulfoxide, benzyl ethyl ether, dihexyl ether, acetylacetone, isophorone, capronic acid, caprylic acid, 1-octanol, 1-nonanol, benzyl alcohol, benzyl acetate, ethyl benzoate, diethyl oxalate, diethyl maleate, γ-butyrolactone, ethylene carbonate, propylene carbonate, phenyl cellosolve acetate, etc.;

[0294] For example, the above solvent preferably uses glycol ethers such as ethylene glycol monoethyl ether and ethylene diglycol methyl ethyl ether; ethylene glycol alkyl ether acetates such as ethyl cellosolve acetate; esters such as ethyl 2-hydroxypropionate; carbitols such as diethylene glycol monomethyl ether; propylene glycol alkyl ether acetates such as propylene glycol monomethyl ether acetate and propylene glycol propyl ether acetate; alcohols such as ethanol or a combination thereof.

[0295] For example, the solvent may be a polar solvent comprising propylene glycol monomethyl ether acetate, dipropylene glycol methyl ether acetate, ethanol, ethylene glycol dimethyl ether, ethylene diglycol methyl ethyl ether, diethylene glycol dimethyl ether, 2-butoxyethanol, N-methylpyrrolidine, N-ethylpyrrolidine, propylene carbonate, γ-butyrolactone, or a combination thereof.

[0296] The above solvent may be included in an amount of 40% to 80% by weight, for example, 45% to 80% by weight, relative to the total amount of the curable composition. When the solvent is included within the above range, the solvent-type curable composition has an appropriate viscosity, so it can have excellent coating properties when performing large-area coating using spin coating and slits.

[0298] Another embodiment provides the curable composition, for example, a cured film manufactured using the curable composition, a color filter comprising the cured film, and a display device comprising the color filter. For example, the display device may include a micro LED light source.

[0299] One of the methods for manufacturing the above-mentioned curable film comprises the step of forming a pattern by applying the above-mentioned curable composition onto a substrate using an inkjet spraying method (S1); and the step of curing the pattern (S2).

[0300] (S1) Step of forming a pattern

[0301] It is preferable to apply the above-mentioned curable composition onto a substrate with a thickness of 0.5 to 20 μm using an inkjet dispersion method. The inkjet spraying can form a pattern by spraying only a single color per nozzle and spraying repeatedly according to the required number of colors, or the pattern can be formed by spraying the required number of colors simultaneously through each inkjet nozzle to reduce the process.

[0302] (S2) Curing step

[0303] Pixels can be obtained by curing the pattern obtained above. At this time, both a thermal curing process and a photocuring process can be applied as the curing method. In the thermal curing process, it is preferable to cure by heating to a temperature of 100°C or higher, more preferably by heating to 100°C to 300°C, and slightly more preferably by heating to 160°C to 250°C. In the photocuring process, active rays such as UV rays of 190 nm to 450 nm, for example 200 nm to 400 nm, are irradiated. Depending on the case, a low-pressure mercury lamp, a high-pressure mercury lamp, an ultra-high-pressure mercury lamp, a metal halide lamp, an argon gas laser, an i-line, KrF, ArF, I-ArF, EUV, X-rays, and electron beams may be used as the light source for irradiation.

[0304] Another method for manufacturing the above-mentioned cured film is to manufacture the cured film using a lithography method with the above-mentioned curable composition, and the manufacturing method is as follows.

[0305] (1) Application and film formation step

[0306] The above curable composition is applied to a substrate that has undergone a predetermined pretreatment using a spin or slit coating method, a roll coating method, a screen printing method, an applicator method, etc., to a desired thickness, for example, 2㎛ to 10㎛, and then a coating film is formed by removing the solvent by heating at a temperature of 70℃ to 90℃ for 1 minute to 10 minutes.

[0307] (2) Exposure step

[0308] In order to form a pattern required on the above-mentioned coating film, a mask of a predetermined shape is interposed, and then an active line such as a UV light of 190 nm to 450 nm, for example 200 nm to 400 nm, is irradiated. Depending on the case, a low-pressure mercury lamp, a high-pressure mercury lamp, an ultra-high-pressure mercury lamp, a metal halide lamp, an argon gas laser, an i-line, KrF, ArF, I-ArF, EUV, X-rays, and electron beams may be used as the light source for irradiation.

[0309] The exposure amount varies depending on the type, mixing amount, and dry film thickness of each component of the above-mentioned curable composition, but, for example, when using a high-pressure mercury lamp, it is 500 mJ / cm² 2 It is less than (based on a 365 nm sensor).

[0310] (3) Phenomenon stage

[0311] Following the above exposure step, an alkaline aqueous solution is used as a developer to dissolve and remove unnecessary parts, thereby leaving only the exposed areas to form an image pattern. That is, when developed with an alkaline developer, the unexposed areas are dissolved, and an image color filter pattern is formed.

[0312] (4) Post-processing step

[0313] The image pattern obtained by the above phenomenon can be cured by reheating or irradiating with active rays to obtain a pattern that is excellent in terms of heat resistance, light resistance, adhesion, crack resistance, chemical resistance, high strength, storage stability, etc.

[0315] Preferred embodiments of the present invention are described below. However, the following embodiments are merely preferred embodiments of the present invention, and the present invention is not limited by the following embodiments.

[0317] (Synthesis of surface modification materials)

[0318] Synthesis Example 1

[0319] 46 mmol of 4,4-difluorobenzophenone, 92 mmol of potassium carbonate, and 101 mmol of 4-methoxyphenol were added to 200 ml of dimethylacetamide (DMAc) and reacted at 120°C for 6 hours, then 30 ml of toluene was added and reacted for an additional 6 hours. Afterward, the mixture was precipitated in distilled water and filtered. The precipitated product was then recrystallized in toluene, 46 mmol of glycidol was added to 100 ml of dibutyltin dilaurate, and reacted at 60°C for 3 hours to synthesize a compound represented by the chemical formula 2-1-1 below.

[0320] [Chemical Formula 2-1-1]

[0321]

[0323] Synthesis Example 2

[0324] 66 mmol of phenyl isocyanate, 92 mmol of potassium carbonate, and 101 mmol of 4-methoxyphenol were added to 200 ml of dimethylacetamide (DMAc) and reacted at 120°C for 6 hours, then 30 ml of toluene was added and reacted for an additional 6 hours. Afterward, the mixture was precipitated in distilled water and filtered. The precipitated product was then recrystallized in toluene, 40 mmol of 1,4-propanesultone was added to 100 ml of dibutyltin dilaurate, and reacted at 40°C for 3 hours to synthesize a compound represented by the chemical formula 2-2-1 below.

[0325] [Chemical Formula 2-2-1]

[0326]

[0328] Synthesis Example 3

[0329] A compound represented by the following chemical formula 2-3-1 was synthesized by carrying out the same procedure as Synthesis Example 2, except that 40 mmol of sulfonamide was used instead of 1,4-propanesultone.

[0330] [Chemical Formula 2-3-1]

[0331]

[0333] Synthesis Example 4

[0334] A compound represented by the following chemical formula 2-4-1 was synthesized by carrying out the same procedure as Synthesis Example 1, except that 15 mmol of hydroxylamine was used instead of 4,4-difluorobenzophenone and the reaction was carried out at 40°C for 3 hours.

[0335] [Chemical Formula 2-4-1]

[0336]

[0337] Synthesis Example 5

[0338] A compound represented by the following chemical formula 2-5-1 was synthesized by carrying out the same procedure as Synthesis Example 2, except that 15 mmol of hydroxylamine was used instead of 1,4-propanesultone.

[0339] [Chemical Formula 2-5-1]

[0340]

[0342] Synthesis Example 6

[0343] A compound represented by the following chemical formula 2-6-1 was synthesized by carrying out the same procedure as Synthesis Example 2, except that 25 mmol of isopropylamine was used instead of 1,4-propanesultone.

[0344] [Chemical Formula 2-6-1]

[0345]

[0347] Comparative Synthesis Example 1

[0348] 28 mmol of hydroquinone was dissolved in 100 ml of acetic acid, 30 ml of hydrobromic acid was added, and the mixture was reacted at 80°C for 6 hours, then 46 mmol of glycidol was added and the mixture was reacted for an additional 40 hours. Afterward, the mixture was precipitated in distilled water, filtered, and then recrystallized with a mixture of water and ethanol (w / w=10:90) to synthesize a compound represented by the chemical formula C-1 below.

[0349] [Chemical Formula C-1]

[0350]

[0352] Comparative Synthesis Example 2

[0353] A compound represented by the following chemical formula C-2 was synthesized by carrying out the comparative synthesis in the same manner as in 1, except that n-phenyl-1-naphthylamine was used instead of hydroquinone.

[0354] [Chemical Formula C-2]

[0355]

[0357] Comparative Synthesis Example 3

[0358] 46 mmol of glycidol and 28 mmol of n-phenyl-1-naphthylamine were added to 100 ml of dibutyltin dilaurate and reacted at 60°C for 3 hours, then 30 ml of toluene was added and reacted for an additional 6 hours. Afterward, the mixture was precipitated in distilled water, filtered, and recrystallized in toluene to synthesize a compound represented by the chemical formula C-3 below.

[0359] [Chemical Formula C-3]

[0360]

[0362] Comparative Synthesis Example 4

[0363] A compound represented by the following chemical formula C-4 was synthesized by carrying out the same procedure as Comparative Synthesis Example 1, except that n-phenyl-1-naphthylamine was used instead of hydroquinone and 35 mmol of methyl allyl ketone was used instead of glycidol.

[0364] [Chemical Formula C-4]

[0365]

[0367] Comparative Synthesis Example 5

[0368] A compound represented by the following chemical formula C-5 was synthesized by carrying out the same procedure as Comparative Synthesis Example 4, except that 25 mmol of methyl allyl ketone was used instead of methyl allyl ketone.

[0369] [Chemical Formula C-5]

[0370]

[0372] (Preparation of surface-modified quantum dots)

[0373] Preparation Examples 1 to 6 and Comparative Preparation Examples 1 to 5

[0374] A magnetic bar is placed in a three-necked round-bottom flask, and a green quantum dot dispersion solution (InP / ZnSe / ZnS, Hansol Chemical; quantum dot solid content 26 wt%) is added. A surface modification material according to Table 1 below is added to this, and the mixture is stirred at 80°C under a nitrogen atmosphere. After the reaction is finished, the mixture is cooled to room temperature (23°C), and then the quantum dot reaction solution is added to cyclohexane to form a precipitate. The precipitate and cyclohexane are separated by centrifugation, and the precipitate is sufficiently dried in a vacuum oven for one day to obtain surface-modified green quantum dots.

[0376] (weight%) Surface modification material Preparation Example 1 Compound of chemical formula 2-1-1 Preparation Example 2 Compound of chemical formula 2-2-1 Preparation Example 3 Compound of chemical formula 2-3-1 Preparation Example 4 Compound of chemical formula 2-4-1 Preparation Example 5 Compound of chemical formula 2-5-1 Preparation Example 6 Compound of chemical formula 2-6-1 Comparative Manufacturing Example 1 Compound of chemical formula C-1 Comparative Manufacturing Example 2 Compound of chemical formula C-2 Comparative Manufacturing Example 3 Compound of chemical formula C-3 Comparative Manufacturing Example 4 Compound of chemical formula C-4 Comparative Manufacturing Example 5 Compound of chemical formula C-5

[0378] (Preparation of curable composition)

[0379] Based on each of the following components, curable compositions according to Examples 1 to 12 and Comparative Examples 1 to 12 were prepared.

[0380] (A) Quantum Dot

[0381] (A-1) Surface-modified green quantum dots prepared from Preparation Example 1 above

[0382] (A-2) Surface-modified green quantum dots prepared from Preparation Example 2 above

[0383] (A-3) Surface-modified green quantum dots prepared from Preparation Example 3 above

[0384] (A-4) Surface-modified green quantum dots prepared from Preparation Example 4 above

[0385] (A-5) Surface-modified green quantum dots prepared from Preparation Example 5 above

[0386] (A-6) Surface-modified green quantum dots prepared from Preparation Example 6 above

[0387] (A-7) Surface-modified green quantum dots prepared from Comparative Example 1 above

[0388] (A-8) Surface-modified green quantum dots prepared from Comparative Example 2 above

[0389] (A-9) Surface-modified green quantum dots prepared from Comparative Example 3 above

[0390] (A-10) Surface-modified green quantum dots prepared from Comparative Example 4 above

[0391] (A-11) Surface-modified green quantum dots prepared from Comparative Example 5 above

[0392] (A-12) Green quantum dots not surface-modified with a surface-modifying material

[0393] (B) Polymerizable compounds

[0394] Compound represented by the following chemical formula 6-2 (M200, Miwon Chemical Co.)

[0395] [Chemical Formula 6-2]

[0396]

[0397] (C) Photopolymerization initiator

[0398] TPO-L (Polynetron)

[0399] (D) Light diffusing agent

[0400] Titanium dioxide dispersion (rutile type TiO2; D50 (180 nm), solid content 50 wt%, Iridos Co., Ltd.)

[0401] (E) Polymerization inhibitor

[0402] Methylhydroquinone (TOKYO CHEMICAL)

[0404] Examples 1 to 6 and Comparative Examples 1 to 6

[0405] Specifically, the surface-modified green quantum dots and the polymerizable compound are mixed and stirred for 12 hours. A polymerization inhibitor is added and stirred for 5 minutes. Then, if necessary, a photopolymerization initiator is added, followed by the addition of a light diffusing agent.

[0406] (Taking Example 1 as an example, a green quantum dot dispersion is prepared by mixing and stirring 41g of a surface-modified green quantum dot with 41g of a polymerizable compound represented by Chemical Formula 6-2, then adding 10.95g of another curable monomer represented by Chemical Formula 6-2 and 0.05g of a polymerization inhibitor to the mixture and stirring for 5 minutes, and then adding 3g of a photopolymerization initiator and 4g of a light diffusing agent and stirring to prepare a curable composition (ink).)

[0407] The specific composition is shown in Table 2 below.

[0409] (Unit: weight%) Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 Comparative Example 5 Comparative Example 6 quantum dots (A-1) 41 - - - - - - - - - - - (A-2) - 41 - - - - - - - - - - (A-3) - - 41 - - - - - - - - - (A-4) - - - 41 - - - - - - - - (A-5) - - - - 41 - - - - - - - (A-6) - - - - - 41 - - - - - - (A-7) - - - - - - 41 - - - - - (A-8) - - - - - - - 41 - - - - (A-9) - - - - - - - - 41 - - - (A-10) - - - - - - - - - 41 - - (A-11) - - - - - - - - - - 41 - (A-12) - - - - - - - - - - - 41 Polymerizable compound (for dispersion) 41 polymerizable compounds 10.95 polymerization inhibitor 0.5 Photopolymerization initiator 3 light diffuser 4

[0411] Evaluation: Evaluation of the light efficiency of curable compositions

[0412] The light efficiency of each curable composition according to Examples 1 to 6 and Comparative Examples 1 to 6 was evaluated, and the results are shown in Table 3 below.

[0414] (Method for evaluating light efficiency)

[0415] A single-film specimen coated with the above-prepared curable composition to a thickness of about 10 nm was prepared, and the change in luminous efficiency was measured under blue 20,000 nit light source conditions using a self-made blue LED surface light source.

[0416] The light conversion rate and light retention rate of the single-film specimens were measured using an integrating sphere instrument (QE-2100, Otsuka Electronics).

[0417] The light retention rate was calculated based on the following formula.

[0418] * Light retention rate (%) = 1 - ((Initial light efficiency - Light efficiency after heat treatment at 180℃ for 30 minutes) / Initial light efficiency)

[0420] Thickness (nm) 450nm Incident Light Absorption Rate (%) Light conversion rate (180℃) (%) Light retention rate (%) Example 1 10.1 97.2 37.5 99.7 Example 2 10.0 98.6 42.5 99.7 Example 3 10.0 98.2 42.1 99.7 Example 4 10.1 96.2 35.6 99.4 Example 5 10.1 96.0 35.5 99.4 Example 6 10.0 95.7 34.9 99.3 Comparative Example 1 10.0 94.0 29.5 88.1 Comparative Example 2 10.2 92.5 32.5 88.8 Comparative Example 3 10.0 93.3 31.8 88.0 Comparative Example 4 10.1 92.9 32.0 88.3 Comparative Example 5 10.1 90.1 27.4 87.4 Comparative Example 6 10.0 90.0 28.2 87.5

[0422] From Table 3 above, it can be confirmed that the curable compositions according to Examples 1 to 6 have superior optical properties compared to the curable compositions according to Comparative Examples 1 to 6.

[0424] The present invention is not limited to the above embodiments and can be manufactured in various different forms, and those skilled in the art will understand that the invention can be implemented in other specific forms without changing the technical concept or essential features of the invention. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive.

Claims

Claim 1 (A) Quantum dots comprising a functional group represented by the following chemical formula 1A; and (B) a curable composition comprising a polymerizable compound: [Chemical Formula 1A] In the above chemical formula 1A, R 1 is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and L 1 Silver single bond, oxygen atom, sulfur atom, NR 2 (R 2 is a hydrogen atom or a C1 to C10 alkyl group) or a substituted or unsubstituted C1 to C20 alkylene group, and L 2 is a substituted or unsubstituted C1 to C2 alkylene group, and L 3 is an oxygen atom or a sulfur atom, m1, m2, n1 and n2 are each independently integers of 0 or 1, p is an integer of 0, and * represents a part connected to an atom constituting the surface of the quantum dot. Claim 2 delete Claim 3 In paragraph 1, the above R 1 A curable composition in which is an epoxy group or a C1 to C20 alkyl group substituted with an epoxy group, wherein m1 is an integer of 1 and m2 is an integer of 0 Claim 4 In paragraph 1, the above R 1 is a thiol group or a C1 to C20 alkyl group substituted with a thiol group, wherein m1 and m2 are each independently an integer of 0, and L 1 A curable composition in which the sulfur atom is Claim 5 In paragraph 1, the above R 1 is a hydroxyl group or a C1 to C20 alkyl group substituted with a hydroxyl group, and m1 and m2 are each independently an integer of 0, and L 1 A curable composition in which oxygen atoms are present. Claim 6 In paragraph 1, the above R 1 A curable composition in which m1 and m2 are each independently an integer of 0, wherein m1 is an amino group or a C1 to C20 alkyl group substituted with an amino group. Claim 7 The curable composition according to claim 1, wherein the functional group represented by Chemical Formula 1A is represented by any one of the following Chemical Formulas 1-1 to 1-6. [Chemical Formula 1-1] [Chemical Formula 1-2] [Chemical Formula 1-3] [Chemical Formula 1-4] [Chemical Formula 1-5] [Chemical Formula 1-6] In the above chemical formulas 1-1 to 1-6, p is an integer of 0, and * represents a part connected to an atom constituting the surface of the quantum dot. Claim 8 In claim 1, the functional group represented by Chemical Formula 1A is a curable composition derived from a compound represented by Chemical Formula 2A. [Chemical Formula 2A] In the above chemical formula 2A, R 1 is a C1 to C20 alkyl group substituted or unsubstituted with a hydrogen atom, an epoxy group, a thiol group, a hydroxyl group, an amino group, or an 'epoxy group, a thiol group, a hydroxyl group, or an amino group', and L 2 is an unsubstituted C1 or C2 alkylene group, and L 3 is an oxygen atom or a sulfur atom, n1 and n2 are each independently integers of 0 or 1, and p is an integer of 0. Claim 9 In claim 8, the compound represented by Chemical Formula 2A is a curable composition represented by any one of the following Chemical Formulas 2-1 to 2-6. [Chemical Formula 2-1] [Chemical Formula 2-2] [Chemical Formula 2-3] [Chemical Formula 2-4] [Chemical Formula 2-5] [Chemical Formula 2-6] In the above chemical formulas 2-1 to 2-6, p is an integer of 0. Claim 10 In claim 1, the curable composition is a solvent-free curable composition. Claim 11 In claim 10, the solvent-free curable composition comprises, with respect to the total amount of the solvent-free curable composition, 5% to 60% by weight of the quantum dots; and 40% to 95% by weight of the polymerizable compound. Claim 12 In claim 1, the curable composition further comprises a polymerization initiator, a light diffusing agent, a polymerization inhibitor, or a combination thereof. Claim 13 In claim 12, the light diffusing agent is a curable composition comprising barium sulfate, calcium carbonate, titanium dioxide, zirconia, or a combination thereof. Claim 14 In claim 1, the curable composition further comprises a solvent. Claim 15 In claim 14, the curable composition comprises, based on the total weight of the curable composition, 1% to 40% by weight of the quantum dots; 1% to 20% by weight of the polymerizable compound; and 40% to 80% by weight of the solvent. Claim 16 The curable composition of claim 1 further comprises malonic acid; 3-amino-1,2-propanediol; a silane-based coupling agent; a leveling agent; a fluorine-based surfactant; or a combination thereof. Claim 17 A cured film manufactured using a curable composition according to any one of claims 1 and 3 to 16. Claim 18 A display device comprising the cured film of claim 17.

Citation Information

Patent Citations

  • Curable composition, cured layer using the same and display device including cured layer

    KR1020220115442A

  • Semiconductor device, display device, imaging system, and mobile object

    JP2021125492A

  • Curable composition, cured layer using the same and display device including cured layer

    KR1020220115441A